Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313455245> ?p ?o ?g. }
- W4313455245 endingPage "195" @default.
- W4313455245 startingPage "182" @default.
- W4313455245 abstract "The prevalence of osteoporosis is increasing in the United States.To evaluate low bone mass and osteoporosis treatments to prevent fractures.Ovid MEDLINE ALL, Ovid Evidence Based Medicine Reviews: Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and ClinicalTrials.gov from 2014 through February 2022.Adults receiving eligible interventions for low bone mass or osteoporosis. Randomized controlled trials (RCTs) for fracture outcomes, and RCTs and large observational studies (n ≥1000) for harms.Abstracted by 1 reviewer and verified by a second. Independent, dual assessments of risk of bias and certainty of evidence (CoE).We included 34 RCTs (in 100 publications) and 36 observational studies. Bisphosphonates and denosumab reduced hip, clinical and radiographic vertebral, and other clinical fractures in postmenopausal females with osteoporosis (moderate to high CoE). Bisphosphonates for 36 months or more may increase the risk for atypical femoral fractures (AFFs) and osteonecrosis of the jaw (ONJ), but the absolute risks were low. Abaloparatide and teriparatide reduced clinical and radiographic vertebral fractures but increased the risk for withdrawals due to adverse events (WAEs; moderate to high CoE). Raloxifene and bazedoxifene for 36 months or more reduced radiographic vertebral but not clinical fractures (low to moderate CoE). Abaloparatide, teriparatide, and sequential romosozumab, then alendronate, may be more effective than bisphosphonates in reducing clinical fractures for 17 to 24 months in older postmenopausal females at very high fracture risk (low to moderate CoE). Bisphosphonates may reduce clinical fractures in older females with low bone mass (low CoE) and radiographic vertebral fractures in males with osteoporosis (low to moderate CoE).Few studies examined participants with low bone mass, males, or Black-identifying persons, sequential therapy, or treatment beyond 3 years.Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab, followed by alendronate, reduce clinical fractures in postmenopausal females with osteoporosis. Abaloparatide and teriparatide increased WAEs; longer duration bisphosphonate use may increase AFF and ONJ risk though these events were rare.American College of Physicians. (PROSPERO: CRD42021236220)." @default.
- W4313455245 created "2023-01-06" @default.
- W4313455245 creator A5001137551 @default.
- W4313455245 creator A5002279941 @default.
- W4313455245 creator A5021093110 @default.
- W4313455245 creator A5043857984 @default.
- W4313455245 creator A5063712653 @default.
- W4313455245 creator A5081623438 @default.
- W4313455245 date "2023-02-01" @default.
- W4313455245 modified "2023-10-14" @default.
- W4313455245 title "Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians" @default.
- W4313455245 cites W1030819271 @default.
- W4313455245 cites W1521417318 @default.
- W4313455245 cites W1526826623 @default.
- W4313455245 cites W1564047582 @default.
- W4313455245 cites W1573883118 @default.
- W4313455245 cites W1634061676 @default.
- W4313455245 cites W1642058051 @default.
- W4313455245 cites W1822646907 @default.
- W4313455245 cites W1847281587 @default.
- W4313455245 cites W189554621 @default.
- W4313455245 cites W1911703092 @default.
- W4313455245 cites W1969907771 @default.
- W4313455245 cites W1974865907 @default.
- W4313455245 cites W1975810697 @default.
- W4313455245 cites W1976389084 @default.
- W4313455245 cites W1976900035 @default.
- W4313455245 cites W1983099396 @default.
- W4313455245 cites W1990276567 @default.
- W4313455245 cites W1990771263 @default.
- W4313455245 cites W1991819568 @default.
- W4313455245 cites W1993035292 @default.
- W4313455245 cites W1993890399 @default.
- W4313455245 cites W1998723509 @default.
- W4313455245 cites W2002557904 @default.
- W4313455245 cites W2003635599 @default.
- W4313455245 cites W2003863147 @default.
- W4313455245 cites W2004644341 @default.
- W4313455245 cites W2006807516 @default.
- W4313455245 cites W2009168877 @default.
- W4313455245 cites W2010029465 @default.
- W4313455245 cites W2012526885 @default.
- W4313455245 cites W2014026700 @default.
- W4313455245 cites W2014106716 @default.
- W4313455245 cites W2015755164 @default.
- W4313455245 cites W2016166586 @default.
- W4313455245 cites W2016874382 @default.
- W4313455245 cites W2019292020 @default.
- W4313455245 cites W2025655954 @default.
- W4313455245 cites W2035408220 @default.
- W4313455245 cites W2039570078 @default.
- W4313455245 cites W2040386786 @default.
- W4313455245 cites W2043658819 @default.
- W4313455245 cites W2045608566 @default.
- W4313455245 cites W2053437224 @default.
- W4313455245 cites W2062464921 @default.
- W4313455245 cites W2072201800 @default.
- W4313455245 cites W2073817578 @default.
- W4313455245 cites W2076490579 @default.
- W4313455245 cites W2077791150 @default.
- W4313455245 cites W2078197973 @default.
- W4313455245 cites W2085270198 @default.
- W4313455245 cites W2085717531 @default.
- W4313455245 cites W2085739273 @default.
- W4313455245 cites W2087574295 @default.
- W4313455245 cites W2094185090 @default.
- W4313455245 cites W2095451755 @default.
- W4313455245 cites W2099054178 @default.
- W4313455245 cites W2099385877 @default.
- W4313455245 cites W2104818602 @default.
- W4313455245 cites W2106202776 @default.
- W4313455245 cites W2106406207 @default.
- W4313455245 cites W2111387898 @default.
- W4313455245 cites W2112629831 @default.
- W4313455245 cites W2123816368 @default.
- W4313455245 cites W2124527463 @default.
- W4313455245 cites W2125435699 @default.
- W4313455245 cites W2128841980 @default.
- W4313455245 cites W2135241080 @default.
- W4313455245 cites W2135327653 @default.
- W4313455245 cites W2136148821 @default.
- W4313455245 cites W2139020001 @default.
- W4313455245 cites W2140978758 @default.
- W4313455245 cites W2141737197 @default.
- W4313455245 cites W2142900141 @default.
- W4313455245 cites W2143254851 @default.
- W4313455245 cites W2147410460 @default.
- W4313455245 cites W2151825217 @default.
- W4313455245 cites W2153009489 @default.
- W4313455245 cites W2160005424 @default.
- W4313455245 cites W2161837912 @default.
- W4313455245 cites W2163830908 @default.
- W4313455245 cites W2163912097 @default.
- W4313455245 cites W2165010366 @default.
- W4313455245 cites W2170750104 @default.
- W4313455245 cites W2178625365 @default.
- W4313455245 cites W2227421250 @default.
- W4313455245 cites W2271621597 @default.